HuagongsheHuagongshe Chemistry Print Report · For research reference only
n-(3-(4-(1h-Indazol-5-ylamino)-6-(2-(pyrrolidin-1-yl)ethoxy)quinazolin-2-yl)phenyl)butyramide di-hydrochloride salt → N-(3-(4-(1H-Indazol-5-ylamino)-6-(2-(pyrrolidin-1-yl)ethoxy)quinazolin-2-yl)phenyl)butyramide
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | n-(3-(4-(1h-Indazol-5-ylamino)-6-(2-(pyrrolidin-1-yl)ethoxy)quinazolin-2-yl)phenyl)butyramide di-hydrochloride salt | HCID 66826580 | — |
| Solvent | Hydrochloric Acid | HCID 313 | — |
| Product | N-(3-(4-(1H-Indazol-5-ylamino)-6-(2-(pyrrolidin-1-yl)ethoxy)quinazolin-2-yl)phenyl)butyramide | HCID 25012088 | — |
Reaction Steps
The purified solid was taken up in HCl (4M in 1,4 dioxane, 2 mL) and stirred at RT for 2 h. The volatiles were removed in vacuo to give N-(3-(4-(1H-indazol-5-ylamino)-6-(2-(pyrrolidin-1-yl)ethoxy)quinazolin-2-yl)phenyl)butyramide di-hydrochloride salt (0.120 g, 0.198 mmol, 70% over two steps). MS 536 (M+1). HPLC retention time 4.61 mins.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US08357693B2 |
| Source dataset | uspto-grants-2013_01 |
| ORD ID | ord-ee5c6f1445054ad98374712b02309e18 |
| Source note | uspto-grants-2013_01 |